NEW YORK (GenomeWeb) – PerkinElmer after the close of the market on Thursday reported a 1 percent dip year over year in its first quarter revenues, though on a constant-currency basis it had revenue growth of 5 percent.

For the three months ended March 29, 2015, PerkinElmer's revenues decreased to $526.9 million from $530.6 million in the prior-year period. Adjusted revenues for the quarter were $527.2 million compared to $532.1 million for Q1 2014, as the firm fell short of the average Wall Street estimate for revenues of $537.9 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.